a, Correlation of high expression of PARL and STARD7 with the resistance of cancer cell lines to the GPX4 inhibitors ML210, ML162 and RSL3. Data were mined from CTRP and show z-scores of Pearson’s correlation coefficients. The central band of each box is the 50% quantile, and the box defines the 25% (lower) and 75% (higher) quantile. The whiskers represent the minimum and maximum value in the data, and outliers are indicated by a plus sign (greater distance than 1.8 times interquantile range away from the median). b, Scheme illustrating FSP1-CoQ- and GPX4-dependent oxidative defence pathways as two independent mechanisms protecting against lipid peroxidation and ferroptosis (image created with BioRender.com). c,d, Ferroptosis was induced in WT, PARL−/− and STARD7−/− HeLa cells with either erastin (3 µM) + PUFA (arachidonic acid 20:4, 40 µM) (n = 3 biologically independent experiments) (c) or RSL3 (200 nM) (d) in the presence of ferrostatin-1 (Fer1, 1 µM) and CoQ2 (1 µM) as indicated, and cell death was monitored after 24 h (n = 2). e,f, Total CoQ10/9 levels in WT, PARL−/− and STARD7−/− HCT116 cells. #1 and #2 represent two different clones of indicated genotype. g,h, Increased ferroptotic vulnerability of two different clones of PARL−/− and STARD7−/− HCT116 cells compared with WT upon treatment with indicated concentrations of erastin for 24 h. i, Cell death in WT, STARD7−/− and in STARD7−/− cells expressing mito-STARD7, cyto-STARD7 or STARD7 after 9 h in the presence of the indicated compounds. j, Representative images from i showing dead cells in magenta and living cells with phase contrast after 9 h. In c–i, data were analysed by Instant Clue software and are represented by 95% confidence interval of the mean. n = 3 (d,i), n = 5 (e,f) and n = 4 (g,h) biologically independent experiments. In c–i, the P values were calculated using a two-tailed Student’s t-test for unpaired comparisons. Source numerical data are available in source data.
Source data